knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 00:59:43 - browse：1651

Portrait of Robert Langer. -- biotech coverage from STAT. — Serial biotech entrepreneur Bob Langer will serve as an adviser to T.rx Capital. Pat Greenhouse/Globe Staff

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer.

Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT. Michael Langer, the son of Bob Langer, confirmed the news and that they had set a $175 million cap for its first fund.

The firm will invest in therapeutics and digital health products by both forming new companies and taking pitches from early-stage startups. T.rx has brought in Everly Health executive Liz Kwo and Caris Life Sciences vice president Debbie Lin as venture partners, while current Eli Lilly business development team member Kwesi Frimpong-Boateng will be joining T.rx’s founding team. Bob Langer is a scientific adviser.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Alabama IVF ruling threatens families facing fatal genetic disease

hotspot

WSS

How faith leaders like me can help address America's obesity epidemic

'Essentially witchcraft:' A former naturopath takes on the field

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Study: Why relieving medical debt did not improve financial outcomes

STAT readers on older presidents, polypills, Medicare, and more

focus

knowledge

knowledge

Jerome Adams on the need for new antivirals for Covid

Community Health Systems hospitals under DOJ investigation

Medical leaders decry Supreme Court decision on affirmative action

A solution to the after

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

The high cost of giving birth even with insurance

'Essentially witchcraft:' A former naturopath takes on the field

Affirmative action in medical school literally saved lives

With competition flaring, obesity drug hits goal in liver disease study

Wikipedia

Dario to buy mental health app maker Twill in cash and stock deal

6 phony surgeries that take placebo to the extreme

How faith leaders like me can help address America's obesity epidemic

California wildfire smoke linked to 52,000 early deaths, study says

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Readers discuss the intersection of pregnancy and addiction

focus

hotspot

knowledge

focus